Arthur T. Skarin, MD, FACP, FCCP and Paul Lorigan, MB, FRCP
Written by highly eminent authors, Lung Cancer - a handbook in the Dana-Farber Cancer Institute series - is produced in full color and is richly illustrated throughout, providing a review of each cancer including its incidence, epidemiology, etiology and histopathology, together with the clinical features. Diagnostic studies and current clinical and pathological staging are also given. Detailed tables are provided with histopathological classification, diagnostic studies and, when important, prognostic factors. Current therapies are also discussed in detail, particularly the management of metastatic lung disease in the context of new and emerging treatments.
Comprehensive coverage - from risk and prevention, and screening and diagnosis, through to treatment options (surgery, chemotherapy, radiation therapy, biological response modifiers)
Attractively designed aids with instant access to the information
Contains useful algorithms to aid management decisions
Discusses practical management of problems in cancer therapy including fever, vomiting, alopecia, fatigue, pain and cachexia
Provides practical advice regarding drug administration
Linked to the hugely successful Dana-Farber Atlas of Diagnostic Oncology
Edited by Arthur T. Skarin, MD, FACP, FCCP, Associate Professor of Medicine, Harvard Medical School, Boston, MA, USA; Senior Attending Physician, Dana-Farber Cancer Institute, Boston, MA, USA; and Paul Lorigan, MB, FRCP, Senior Lecturer in Medical Oncology, Christie Hospital NHS Trust, Manchester, UK
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and handheld, we are able to supply the information you need in the most convenient format.